Source: International Congress 2018 – Pulmonary hypertension: therapy
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Marra (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), C. Fischer (Heidelberg, Germany), H. Gall (Giessen, Germany), H. Ghofrani (Giessen, Germany), M. Halank (Dresden, Germany), M. Hoeper (Hannover, Germany), T. Lange (Regensburg, Germany), K. Olsson (Hannover, Germany), E. Grünig (Heidelberg, Germany). Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study). 3042

Member's Comments

No comment yet.

Related content which might interest you: Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009 Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Sleep Disordered Breathing (SDB) and Chronic Thromboembolic Pulmonary Hypertension: the Effects of Pulmonary Endoarterectomy Source: International Congress 2017 – CPAP therapy Year: 2017 Interventional Treatment in Chronic Thromboembolic Pulmonary Hypertension with Microvasculopathy Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Supraventricular Arrhythmias in Pulmonary Arterial Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension Year: 2018 Chronic Thromboembolic Pulmonary Hypertension related to ICD Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension Year: 2018 A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Iron Deficiency in Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Clinical Features of Pulmonary Hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012